Trial Search Results

Side Effects of Pulmonary Hypertension Medications

The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric population. This information can better improve patient care and be used to characterize the side effects resultant from these medications.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Phase:

N/A

Eligibility


Inclusion Criteria:

   - pulmonary hypertension

   - currently taking at least one of the following PH medications (Bosentan, Epoprostenol,
   Letairis, Sildenafil, Tadalafil, Treprostinil, Ventaris)

Exclusion Criteria:

   - >18 years

Ages Eligible for Study

N/A - 18 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jeffrey Feinstein, MD, MPH
650-723-7913
Recruiting